Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

Author: Van Cutsem E.   Cunningham D.   Ten Bokkel Huinink W.W.   Punt C.J.A.   Alexopoulos C.G.   Dirix L.   Symann M.   Blijham G.H.   Cholet P.   Fillet G.   Van Groeningen C.   Vannetzel J.M.   Levi F.   Panagos G.   Unger C.   Wils J.   Cote C.   Blanc C.   Herait P.   Bleiberg H.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.35, Iss.1, 1999-01, pp. : 54-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content